FIELD: chemistry.
SUBSTANCE: compounds can be used to treat diseases mediated by the nicotinic acetylcholine receptor, such as derangement of memory. In general formulae , and A is an indazolyl, benzothiazolyl or isobenzothiazolyl group which corresponds to structural formulae a) to c) respectively or X is O; R1 is H, F, Cl, Br, I, cycloalkyl containing 3-7 carbon atoms, alkoxy which contains 1-4 carbon atoms, fluorinated alkoxy which contains 1-4 carbon atoms, Ar or Het; ; R2 is H; R3 is H; R4 is H, F, Cl, Br, I, cycloalkyl which contains 3-7 carbon atoms, alkoxy which contains 1-4 carbon atoms, fluorinated alkoxy which contains 1-4 carbon atoms, Ar or Het; R5 is H; Ar is an aryl group containing 6 carbon atoms which is unsubstituted or substituted once or several times with halogen; and Het is a 5- or 6-member heteroaromatic group containing a heteroatom in the ring which is selected from N, O and S, or a 6-member saturated heterocyclic group which contains a heteroatom in the ring which is selected from N and O; and their pharmaceutically acceptable salts, where, if the said compound has formula I, the indazolyl group of group A is bonded through its 3rd, 4th or 7th position, the benzothiazole group of group A is bonded through the 4th or 7th position, the isobenzothiazole group of group A is bonded through the 3rd, 4th or 7th position.
EFFECT: obtaining compounds with properties of nicotinic acetylcholine receptor (nAChR) ligands, and pharmaceutical compositions based on the said compounds.
53 cl, 95 ex
Title | Year | Author | Number |
---|---|---|---|
INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZOISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, PREPARING AND USING THEM | 2006 |
|
RU2450003C2 |
INDAZOLES, BENTOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES AND SYNTHESIS AND USE THEREOF | 2005 |
|
RU2417225C2 |
DERIVATIVES OF QUINUCLIDINEAMIDE, METHOD FOR THEIR PREPARING AND THEIR USING, PHARMACEUTICAL COMPOSITION, COMBINED PRODUCT AND METHOD FOR INHIBITION OF MUSCARINIC RECEPTORS | 2003 |
|
RU2314306C2 |
MODULATION OF INFLAMMATORY AND METASTATIC PROCESSES | 2005 |
|
RU2377988C2 |
LIGANDS OF NICOTINE RECEPTOR α, THEIR OBTAINING AND APPLICATION | 2005 |
|
RU2418797C2 |
(2S,3R-)-N-(2-((3-PYRIDINYL)METHYL)-1-AZABICYCLO[2,2,2]OCT-3-YL)BENZOFURANE-2-CARBOXAMIDE, NEW SALT FORMS AND METHODS FOR PREPARING THEM | 2008 |
|
RU2476220C2 |
METHOD OF TREATMENT OR PROPHYLAXIS OF MAMMALS AND HUMAN WITH VOMITING USING SOME QUINUCLIDINE, PIPERIDINE, AZANORBORNANE, ETHYLENEDIAMINE DERIVATIVES AND RELATED COMPOUNDS | 1994 |
|
RU2135179C1 |
N-(1-(1-BENZYL-4-PHENYL-1H-IMIDAZOL-2-YL)-2,2-DIMETHYLPROPYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPINDLE PROTEIN (KSP) INHIBITORS FOR TREATING CANCER | 2005 |
|
RU2427572C2 |
APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
QUINUCLIDINE CARBAMATES, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2296762C2 |
Authors
Dates
2010-06-10—Published
2003-09-25—Filed